Kyowa Hakko USA Inc., New York, announced the results of a randomized, double-blind, placebo-controlled human clinical trial conducted by The Brain Institute at the University of Utah. The study found that adolescent males experienced increased motor speed and attention after supplementation of Cognizin citicoline.